<DOC>
	<DOCNO>NCT01482780</DOCNO>
	<brief_summary>The aim study analyze potential pressure control intermittent coronary sinus occlusion ( PICSO ) prevent/reverse ischemic burden well reperfusion injury . To achieve insight clinical significance local precondition effect , global hemodynamics , cardiac performance clinical outcome first 30 day relate ability intervention protect myocardium elective surgical procedure , ameliorate cellular decay preserve microcirculation therefore improve graft flow , reduce enzyme leakage finally improve myocardial performance .</brief_summary>
	<brief_title>Evaluation Local Preconditioning Effect Patients Undergoing Cardiac Surgery</brief_title>
	<detailed_description>- Patients undergo elective coronary artery bypass graft ( CABG ) enrol study . - A computerized randomization process use obtain similar distribution within group . Stratification do severity coronary artery disease , age sex . - Routine blood sample perform day surgery well transthoracic echocardiography ( TTE ) study determine ventricular volume valvular function . - A modified Minnesota quality Life questionnaire assess data compare 30 day outcome data screen outpatient environment . - A 12 lead electrocardiogram obtain . To assess eligibility assure grouping ( stratification &amp; randomization ) patient score use additive EuroSCORE . Pre- , intra- , postoperative ( 72 hr ) measurements myocardial enzyme leakage perform use standard diagnostic procedure ( cardiac troponin T , CK-MB , total creatine kinase ) , well serial electrocardiogram echocardiograms . - Perioperative infarction assess development new persistent regional wall motion abnormality echocardiography together electrocardiographic alteration CK-MB increase new Q-wave PMI . - Sequential cytokine analysis ( IL-1 , IL-6 , IL-8 , IL-10 , IL-17 , VEGF TNF- alpha ) preoperatively , begin operation , begin ECC 6,24 h 30 day postop . - Serial quantification global regional wall motion record use TEE measurement surgery .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Adult patient either sex 18 85 year age schedule surgery without severe confound disease ask participate study . Written inform consent obtain eligible patient . Patients unstable angina pectoris and/or myocardial infarction within last 30 day , well person plan concomitant valvular intervention exclude . Patients malignoma , severe hepatic , renal pulmonary disease also exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>